RNA-mediated toxicity in C9orf72 ALS and FTD

被引:28
|
作者
McEachin, Zachary T. [1 ,2 ]
Parameswaran, Janani [1 ]
Raj, Nisha [1 ,2 ]
Bassell, Gary J. [1 ,2 ,3 ]
Jiang, Jie [1 ]
机构
[1] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA
[2] Emory Univ, Lab Translat Cell Biol, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
关键词
Amyotrophic lateral sclerosis; Frontotemporal dementia; C9orf72; RNA-mediated toxicity; RNA foci; Dipeptide repeat proteins; Antisense oligonucleotide; FRONTOTEMPORAL LOBAR DEGENERATION; DIPEPTIDE REPEAT PROTEINS; AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; PATHOLOGICAL FEATURES; ANTISENSE RNA; MUSCLEBLIND PROTEINS; TDP-43; PATHOLOGY; SMALL MOLECULES; IN-VITRO;
D O I
10.1016/j.nbd.2020.105055
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A GGGGCC hexanucleotide repeat expansion in the first intron of C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. Compelling evidence suggests that gain of toxicity from the bidirectionally transcribed repeat expanded RNAs plays a central role in disease pathogenesis. Two potential mechanisms have been proposed including RNA-mediated toxicity and/or the production of toxic dipeptide repeat proteins. In this review, we focus on the role of RNA mediated toxicity in ALS/FTD caused by the C9orf72 mutation and discuss arguments for and against this mechanism. In addition, we summarize how G4C2 repeat RNAs can elicit toxicity and potential therapeutic strategies to mitigate RNA-mediated toxicity.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] The Phenotype of the Hexanucleotide Repeat C9FTD/ALS (C9ORF72)
    Sha, Sharon
    Takada, Leonel
    Rankin, Katherine
    Yokoyama, Jennifer
    Khan, Baber
    Karydas, Anna
    Fong, Jamie
    Rutherford, Nicola
    Baker, Matthew
    DeJesus-Hernandez, Mariely
    Coppola, Giovanni
    Rademakers, Rosa
    Seeley, William
    Miller, Bruce
    Boxer, Adam
    NEUROLOGY, 2012, 78
  • [22] Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
    Sattler, Rita
    Traynor, Bryan J.
    Robertson, Janice
    Van den Bosch, Ludo
    Barmada, Sami J.
    Svendsen, Clive N.
    Disney, Matthew D.
    Gendron, Tania F.
    Wong, Philip C.
    Turner, Martin R.
    Boxer, Adam
    Babu, Suma
    Benatar, Michael
    Kurnellas, Michael
    Rohrer, Jonathan D.
    Donnelly, Christopher J.
    Bustos, Lynette M.
    Van Keuren-Jensen, Kendall
    Dacks, Penny A.
    Sabbagh, Marwan N.
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 1821 - 1843
  • [23] Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
    Rita Sattler
    Bryan J. Traynor
    Janice Robertson
    Ludo Van Den Bosch
    Sami J. Barmada
    Clive N. Svendsen
    Matthew D. Disney
    Tania F. Gendron
    Philip C. Wong
    Martin R. Turner
    Adam Boxer
    Suma Babu
    Michael Benatar
    Michael Kurnellas
    Jonathan D. Rohrer
    Christopher J. Donnelly
    Lynette M. Bustos
    Kendall Van Keuren-Jensen
    Penny A. Dacks
    Marwan N. Sabbagh
    Neurology and Therapy, 2023, 12 : 1821 - 1843
  • [24] Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS
    Jovicic, Ana
    Mertens, Jerome
    Boeynaems, Steven
    Bogaert, Elke
    Chai, Noori
    Yamada, Shizuka B.
    Paul, Joseph W., III
    Sun, Shuying
    Herdy, Joseph R.
    Bieri, Gregor
    Kramer, Nicholas J.
    Gage, Fred H.
    Van den Bosch, Ludo
    Robberecht, Wim
    Gitler, Aaron D.
    NATURE NEUROSCIENCE, 2015, 18 (09) : 1226 - +
  • [25] Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS
    Ana Jovičić
    Jerome Mertens
    Steven Boeynaems
    Elke Bogaert
    Noori Chai
    Shizuka B Yamada
    Joseph W Paul
    Shuying Sun
    Joseph R Herdy
    Gregor Bieri
    Nicholas J Kramer
    Fred H Gage
    Ludo Van Den Bosch
    Wim Robberecht
    Aaron D Gitler
    Nature Neuroscience, 2015, 18 : 1226 - 1229
  • [26] Role of C9orf72 hexanucleotide repeat expansions in ALS/FTD pathogenesis
    Geng, Yanyan
    Cai, Qixu
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2024, 17
  • [27] Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion
    Fong, Jamie C.
    Karydas, Anna M.
    Goldman, Jill S.
    ALZHEIMERS RESEARCH & THERAPY, 2012, 4 (04)
  • [28] Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders
    Maria Sara Cipolat Mis
    Simona Brajkovic
    Francesco Tafuri
    Nereo Bresolin
    Giacomo P. Comi
    Stefania Corti
    Molecular Neurobiology, 2017, 54 : 4466 - 4476
  • [29] The ALS/FTD C9ORF72 Hexanucleotide Expansion Disrupts Nucleocytoplasmic Transport
    Zhang, Ke
    Donnelly, Christopher J.
    Haeusler, Aaron R.
    Sattler, Rita
    Wang, Jiou
    Rothstein, Jeffrey D.
    Lloyd, Thomas E.
    ANNALS OF NEUROLOGY, 2014, 76 : S118 - S118
  • [30] RAN translation in C9orf72 ALS/FTD and other repeat opportunities
    Ranum, L.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S129 - S129